Fabrication of nanowires and hierarchically porous materials through supercritical co2 assisted nebulization
US-2015367038-A1 · Dec 24, 2015 · US
US10322214B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-10322214-B2 |
| Application number | US-201514934645-A |
| Country | US |
| Kind code | B2 |
| Filing date | Nov 6, 2015 |
| Priority date | Nov 6, 2014 |
| Publication date | Jun 18, 2019 |
| Grant date | Jun 18, 2019 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
Biodegradable magnesium alloy implantable medical devices are protected to delay onset of corrosion, and thus biodegradability, or to corrode more uniformly. The protection allows for extended effective use of the devices while maintaining biodegradability. Examples of protective coatings include conversion coatings that at least partially remove exposed second phases from a surface of the magnesium alloy and coatings that provide a barrier between water and the surface of the magnesium alloy.
Opening claim text (preview).
The invention claimed is: 1. A biodegradable implantable medical device, comprising a magnesium (Mg) alloy; and a coating on the Mg alloy, wherein the coating comprises (i) a conversion coating that removes exposed second phases from a surface of the Mg alloy; and (ii) one or more moisture barrier layers; wherein the one or more barrier layers comprise a layer selected from the group consisting of aluminum, magnesium, cerium oxide, aluminum oxide, titanium ethylene glycol, titanium propylene glycol, zirconium oxide, zirconium ethylene glycol, zirconium propylene glycol, hafnium oxide, hafnium ethylene glycol, hafnium propylene glycol, aluminum fluoride, or magnesium fluoride. 2. The biodegradable implantable medical device of claim 1 , wherein the conversion comprises a conversion coating selected from the group consisting of: a hydrofluoric acid (HF) conversion coating; a conversion coating with acidic or basic solutions of Ce 3+ or Ce 4+ ; a conversion coating with an acidic or basic solution comprising an inorganic magnesium precipitating agent; and a conversion coating with an acidic or basic solution comprising an organic magnesium precipitating agent. 3. The biodegradable implantable medical device of claim 1 , wherein the conversion coating comprises an inorganic magnesium precipitating agent selected from the group consisting of a phosphate, a silicate, a permanganate, a hydrotalcite, a vanadate, a chromate and a Rare Earth ion other than a cerium ion. 4. The biodegradable implantable medical device of claim 1 , wherein the conversion coating comprises an organic magnesium precipitating agent selected from the group consisting of 4-(4-nitrophenylazo)-resorcinol, 8-hydroxy quinolone, and sodium dodecylbenzenesulphonate. 5. The biodegradable medical device of claim 1 , wherein the conversion coating comprises an HF conversion coating. 6. The biodegradable medical device of claim 1 , wherein the one or more moisture barrier layers comprise a layer of aluminum oxide and a layer of poly(aluminum ethylene glycol). 7. The biodegradable medical device of claim 1 , wherein the one or more moisture barrier layers comprise a layer of aluminum oxide and a layer of cerium oxide. 8. A biodegradable frame for an implantable medical stent, the frame comprising: a magnesium (Mg) alloy; and a coating on the Mg alloy, wherein the coating comprises a hydrofluoric acid (HF) conversion coating layer on the Mg alloy, and alternating layers of aluminum oxide (Al 2 O 3 ) and a poly(aluminum ethylene glycol) polymer (alucone) on the HF conversion coating layer. 9. The frame of claim 8 , wherein the coating comprises the HF conversion coating layer on the Mg alloy, a base layer of Al 2 O 3 on the HF conversion coating layer, a nanolaminate of Al 2 O 3 and alucone on the base layer of Al 2 O 3 , and a layer of alucone on the nanolaminate of Al 2 O 3 and alucone. 10. The frame of claim 9 , wherein the total thickness of the base layer of Al 2 O 3 , the nanolaminate of Al 2 O 3 and alucone, and the layer of alucone is 100 nanometers or less. 11. A biodegradable frame for an implantable medical stent, the frame comprising: a magnesium (Mg) alloy; and a coating on the Mg alloy, wherein the coating comprises a layer of aluminum oxide and a layer of cerium oxide. 12. A biodegradable frame for an implantable medical stent, the frame comprising: a magnesium (Mg) alloy; and a coating on the Mg alloy, wherein the coating comprises a layer of aluminum oxide and a layer of poly(aluminum ethylene glycol).
characterised by the deposition of metallic material · CPC title
connected peak to trough · CPC title
Coatings comprising two or more layers · CPC title
Carbon; Graphite · CPC title
Other specific inorganic materials not covered by A61L31/084 or A61L31/086 · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.